Skip to content
Menu

OnKure Therapeutics, Inc. OKUR

Full chart Compare
Set alert

Price alert · OKUR

All alert types
2.63 USD -0.38 (-12.62%)

Regular-session close

2.63 0.00 0.00%

After hours · Nov 13, 4:00 PM ET

2.60 Day range 3.08
2.01 52-week range 5.38
YTD
-9.31%
1 year
-16.24%
Market cap
108.33M
EPS (ttm)
-2.26
Shares out
12.65M
Forward P/E
-2.64
YTD return
-9.31%
1-year return
-16.24%
Volume
891.35K
Avg volume
324.10K
Open
3.03
Previous close
3.01
Day's range
2.60 – 3.08
52-week range
2.01 – 5.38
Analysts
Strong Buy
Price target
34.75 (+1221.3%)

5D +0.67 (+28.63%)

2.5033.50FriMonTueWedThu3.01

Key statistics

Enterprise value
240.68M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
0
Total cash
7.96M
Total debt
6.51M
Return on equity
0.00%
Short % of float
0.00%
50-day average
15.50
200-day average
15.91

Fundamental scorecard

4 of 25 checks passed on OKUR’s reported financials

Value: 1/5ValueGrowth: 0/5GrowthProfitability: 0/5ProfitabilityFinancial health: 3/5HealthDividend: 0/5Dividend

4of 25 checks passed

  • Value 1 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
OKUR Revenue — quarterly 0
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OKUR Net income — quarterly -17.85M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OKUR EPS — quarterly -0.36
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

OKUR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.97-1.10-0.13-13.40%

Upgrades / downgrades

OKUR analyst upgrades and downgrades
DateFirmActionFromTo
Dec 5, 2024Leerink Partnersinit—Outperform
Nov 8, 2024HC Wainwright & Co.reitBuyBuy
Oct 10, 2024Oppenheimerinit—Outperform

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on OKUR — it syncs with the Stock Master app.

Insider holders

OKUR insider holders
InsiderRelationLatest transactionDateShares held
CARRUTHERS R MICHAELDirectorStock Award(Grant)Oct 3, 20244,939
GREY MICHAEL G.Officer and DirectorStock GiftJul 25, 2023628,846
HALL ASHLEYOfficerConversion of Exercise of derivative securityAug 27, 202339,600
LEONARD BRADEN MICHAELBeneficial Owner of more than 10% of a Class of SecurityPurchaseSep 24, 20240
LEVERONE JASON A. CPAChief Financial OfficerStock Award(Grant)Oct 3, 202416,331
NOVO HOLDINGS A/SBeneficial Owner of more than 10% of a Class of SecuritySaleJun 22, 20233,330,340

Institution ownership

OKUR institution ownership
Holder% heldSharesValueReported
NEA Management Company, LLC3.78%478,5493.91MSep 29, 2024
BML Capital Management, LLC2.73%345,7402.83MSep 29, 2024
Highbridge Capital Management, LLC.2.42%306,2692.51MSep 29, 2024
Tang Capital Management, LLC2.33%294,6262.41MSep 29, 2024
Carlyle Group Inc.2.13%269,8962.21MSep 29, 2024
Rivervest Venture Management LLC2.00%253,4222.07MSep 29, 2024

Fund ownership

OKUR fund ownership
Holder% heldSharesValueReported
iShares Biotechnology ETF0.51%64,795530.02KOct 30, 2024
Vanguard Total Stock Market Index Fund0.47%59,611487.62KSep 29, 2024
Vanguard Extended Market Index Fund0.22%27,854227.84KSep 29, 2024
Fidelity Extended Market Index Fund0.08%10,53686.18KOct 30, 2024
iShares Micro Cap ETF0.04%4,61437.74KOct 30, 2024
Fidelity Total Market Index Fund0.03%3,59929.44KOct 30, 2024